Noom Inc. Launches Noom Med

Noom, has unveiled its latest offering, Noom Med, a comprehensive program designed to combat obesity by integrating telehealth services and personalised psychological tools for sustainable weight loss. By leveraging Noom's expertise in digital health and psychology-based behaviour change, Noom Med aims to empower patients to overcome the barriers to lasting weight loss and improve their overall health outcomes. The program, led by Chief of Medicine Dr. Linda Anegawa, provides specialised clinical support and health coaching to address obesity and related diseases.

Noom has a proven track record of helping users achieve their health and weight loss goals, recognising that treating obesity can prevent and reduce the risk of chronic illnesses. Internal data reveals that Noom Weight users shed an average of 15 pounds in 16 weeks, with 98% reporting positive habit changes. A separate study demonstrated that 42% of Noom users who achieved a 10% weight loss maintained their results two years after completing the program.

The introduction of GLP-1s (glucagon-like peptide-1) for obesity care has revolutionised the weight loss landscape. Clinical trials have shown significant weight loss achieved with these medications. However, long-term success requires a comprehensive behaviour change program. Noom Med stands out as the only program built upon a psychology-based behaviour program, combining Noom's expertise with personalised clinical support to provide a powerful approach to combat obesity.

Noom's ultimate goal is not just weight loss but also the prevention of chronic illness, the extension of lifespan, and the improvement of quality of life. Managing weight has been linked to a life expectancy increase of three or more years for individuals with a high body mass index and those living with diabetes. Noom believes that by providing personalised and destigmatize weight loss solutions, they can help patients lose weight and potentially add years back to their lives.

Noom Med is available to individuals with a BMI of 30 or higher, or those with a BMI of 27 or higher accompanied by a weight-related medical condition. Patients undergo a health evaluation and comprehensive lab work, and a clinician collaborates with them to create an individualised plan of care. Only eligible users are prescribed medication, and the complete plan is delivered through Noom's mobile app, featuring interactive patient education, a psychologically-aware curriculum, and comprehensive nutrition and exercise tools. The program also offers video connectivity with practitioners, fostering a strong patient-clinician connection, enhancing safety, and promoting engagement in care.

Noom recognises that obesity is not solely a willpower or personal failure issue. The human body's evolutionary biology poses challenges to weight loss, and a comprehensive clinical approach, combined with psychological education and support, is necessary to achieve long-term health outcomes. Noom Med seeks to address these biological factors and empower individuals on their journey to better health.

Click here to read the original news story.